SNC
XBI icon

Stifel Nicolaus & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Stifel Nicolaus & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$652K Sell
15,156
-687
-4% -$27.8K 0.01% 804
2013
Q2 		$551K Buy
+15,843
New +$557K 0.01% 827

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Stifel Nicolaus & Co's XBI Position: Q3 2013 in Review

Stifel Nicolaus & Co reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 4.3% in Q3 2013, selling an estimated $27.8K and leaving 15,156 shares worth $652K. The position accounts for 0.01% of the portfolio, ranked #804.

Stifel Nicolaus & Co first reported a position in XBI in Q2 2013 and has held it in 2 quarters since. 125 funds tracked by Wall St. Rank hold XBI as of Q3 2013.

  • Stifel Nicolaus & Co held 15,156 shares of State Street SPDR S&P Biotech ETF worth $652K as of Q3 2013.
  • Stifel Nicolaus & Co sold 687 State Street SPDR S&P Biotech ETF shares in Q3 2013, an estimated $27.8K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #804 holding.
  • Stifel Nicolaus & Co first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 2 quarters since.
  • 125 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.